Showing results (171-180 of 178) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Nature Communications|February 16, 2018
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptorDavid L Gray, John A Allen, Scot Mente, et al.Brain : a Journal of Neurology|October 24, 2015
Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivityKelly R Bales, Sharon M O'Neill, Nikolay Pozdnyakov, et al.JAMA Neurology|December 8, 2025
Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical TrialGert Jan Lammers, Giuseppe Plazzi, Emmanuel Mignot, et al.Frontiers in Pharmacology|August 1, 2020
Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic ActivationRouba Kozak, Tamás Kiss, Keith Dlugolenski, et al.NPJ Parkinson'S Disease|June 12, 2024
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 monthsJamie L Adams, Tairmae Kangarloo, Yishu Gong, et al.Molecular and Cellular Neurosciences|July 30, 2013
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cellsMatthew F Burkhardt, Fernando J Martinez, Sarah Wright, et al.NPJ Parkinson'S Disease|April 17, 2023
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD studyJamie L Adams, Tairmae Kangarloo, Brian Tracey, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 15, 2020
The 2020 motile active matter roadmapGerhard Gompper, Roland G Winkler, Thomas Speck, et al.Pageof 18